Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Brainimmune is Looking for a Strategic Partner to Advance the Neuroendocrine Immunology and Stress-Immunity Research Field
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
First Evidence That Th22 Cells May Contribute To the Pathogenesis of Graves’ DiseaseSeptember 10, 2014
New Evidence that Peripheral Nerves Sense Infection and Drive IL-23 Production by Skin Dendritic CellsOctober 22, 2015
Inhibitors of RORγt Targeting Th17 Cells May Hold Promising Therapeutic Potential in Inflammation & AutoimmunityJanuary 26, 2016
Vasoactive Intestinal Peptide Inhibits Pathogenic Th17 Cells from Rheumatoid Arthritis PatientsMay 27, 2015
The Th17–IL-17–IL-17R System Linked To Altered Brain Development and Autism-Like Symptoms in MiceMarch 3, 2016
Th17 Cells and Lymphotoxin: Conductors for the Tertiary Lymphoid Tissues and Inflammation OrchestraJuly 1, 2016
